Clinical Trial Supply and Logistics Market To Surpass US$ 27.59 Billion By 2026

Posted August 20, 2021 by SANJAYCMI

Clinical Trial Supply and Logistics Market Report- 2026 Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.
The Global Clinical Trial Supply and Logistics Market, By Service (Manufacturing, Packaging and Labeling, and Distribution), By End User (Pharmaceutical, Medical Devices, and Biologics) was valued at US$ 14.95 Bn in 2017 and is projected to exhibit a CAGR of 7.1% over the forecast period (2018 - 2026), as highlighted in a new report published by Coherent Market Insights.

Various clinical trial supply and logistics management companies are indulged in offering smart tools to solve problems in delivering trial-related supplies to multiple locations, identify opportunities, reduce costs, and enhance future trials. Clinical supply management provides other supplies such as disposable products, refrigerators, centrifuges, and diagnostic, testing, and imaging medical equipment apart from the investigational medicinal products. These factors are expected to create lucrative opportunities for the manufacturers to develop drugs or technologically advanced medical devices with ease.

The shift in geographical distribution of clinical trials by various biopharmaceutical companies from regions such as Central and Eastern Europe, Asia Pacific, Latin America, and Middle East for cost-effective and quick patient recruitment is expected drive growth of the clinical trial supply and logistics market. Furthermore, Asia Pacific region provides greater economic benefits to biopharmaceutical companies, as government in China and Singapore allocate funds to promote biomedical research in the region.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report:

Also, Asia Pacific possess various kind of different diseases, which helps in conducting clinical trials with more significant results and outcome. In April 2018, Zuellig Pharma Holdings Pte. Ltd. entered into a distribution agreement with Taiho Pharma, Singapore for their product, TS-ONE OD Tablet, which is the first anticancer agent in the form of disintegrating tablet for the patients who are facing difficulty in swallowing capsules or whose water intake is restricted.

Browse 25 Market Data Tables and 44 Figures spread through 173 Pages and in-depth TOC on "Clinical Trial Supply and Logistics Market, By Service (Manufacturing, Packaging and Labeling, and Distribution), By End User (Pharmaceutical, Medical Devices, and Biologics) - Global Forecast to 2026"

Clinical trial suppliers and logistics focuses on organic and inorganic growth strategies such as mergers and acquisitions, and launch of various clinical programs, which in turn is expected to augment growth of the market during the forecast period. For instance, in November, 2016, Bionical, global supplier of commercial pharmaceutical products, acquired a global Clinical Research Organisation named EMAS Pharma to expand its clinical service business footprint globally and to unify and complete Bionical’s patient-centric service portfolio.

Browse Research Report:

Key takeaways of the clinical trial supply and logistics market:

The global clinical trial supply and logistics market is expected to expand at a CAGR of 7.1% during the forecast period (2018 – 2026), owing to increasing number of clinical trials, increasing complexities, and rising number of biologics and biosimilar drugs in trials

On the basis of service, distribution segment is expected to show maximum traction during the forecast period, owing to the rising outsourcing storage and distribution facility

On the basis of end user, pharmaceutical segment holds largest market share, owing to increasing research activities for oncology therapeutic application. However, steady decrease in R&D pipeline for pharmaceutical drugs has been observed and it is being substituted by biological drugs, which is expected to impact the segment over the next eight years.

Some of the major players operating in the global clinical trial supply and logistics market include Catalent Pharma Solutions, Inc., Almac Group, Movianto, Patheon, Inc., PCI Pharma Distribution, Sharp Packaging Distribution, PAREXEL International Corporation, Marken, KLIFO A/S, and Biocair

Buy-Now this research report:

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Coherent Market Insights
Phone +1-206-701-6702
Business Address 1001 4th Ave
# 3200 Seattle, WA 98154, U.S.
Country United States
Categories Health , Marketing , Research
Tags clinical trial supply and logistics market , clinical trial supply and logistics market research , clinical trial supply and logistics market size
Last Updated August 20, 2021